Literature DB >> 22963625

Dendrimers in photodynamic therapy.

B Klajnert1, M Rozanek, M Bryszewska.   

Abstract

Photodynamic therapy (PDT) is a promising approach to treat certain types of cancer. PDT was proposed as a useful oncology tool more than 30 years ago but it has limitations. The success of PDT depends predominantly on photosensitizers and development of an effective second generation is continuing. Dendrimers possess architecture suitable for incorporating specific functional moieties and are a promising venue for further investigations. This review describes the use of dendrimers in PDT and how they can aid in overcoming obstacles encountered during PDT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963625     DOI: 10.2174/0929867311209024903

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  4 in total

1.  Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy.

Authors:  Patrícia M R Pereira; Sandrina Silva; José A S Cavaleiro; Carlos A F Ribeiro; João P C Tomé; Rosa Fernandes
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 2.  Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer.

Authors:  Liang Shang; Xinglu Zhou; Jiarui Zhang; Yujie Shi; Lei Zhong
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

3.  Preparation of New Glycerol-Based Dendrimers and Studies on Their Behavior toward Essential Oil Encapsulation.

Authors:  Chloë Maes; Bérengère Menot; Safa Hayouni; Agathe Martinez; Marie-Laure Fauconnier; Sandrine Bouquillon
Journal:  ACS Omega       Date:  2022-03-15

4.  Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.

Authors:  Amreddy Narsireddy; Kurra Vijayashree; Mahesh G Adimoolam; Sunkara V Manorama; Nalam M Rao
Journal:  Int J Nanomedicine       Date:  2015-11-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.